← Back to all trials
Completed
NCT05650021
Rectal Spacer for Prostate Cancer Radiation Image Guidance
Conditions: Prostate Cancer
Sex: Male
Healthy volunteers: No
Phase: NA
Enrollment: 17
Sponsor: Milton S. Hershey Medical Center
Location: Penn State Cancer Institute Hershey Pennsylvania
Summary
The purpose of the study is to determine if a radiopaque hydrogel rectal spacer, SpaceOAR Vue®, can be used in place of fiducial markers when aligning patients for radiotherapy. The investigator hypothesizes that the alignment of the patient based on the rectal spacer will be similar to the alignment of the patient with fiducial markers.
Eligibility Criteria
Inclusion Criteria:
* To be eligible for the study, you must have already had SpaceOAR and fiducial markers placed before undergoing prostate radiotherapy, or you should have a plan to have them placed.
* Untreated cT1 - cT3 prostate cancer
Exclusion Criteria:
* Extracapsular extension of prostate cancer
* Prior prostatectomy
Source: ClinicalTrials.gov (NCT05650021). StuddyBuddy aggregates publicly available trial information.
